Behavioural Sensitisation During Dopamine Replacement Therapy in Parkinson's Disease is Reminiscent of the Addicted Brain

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|10|894-902

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.10, 2009-07, pp. : 894-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Optimisation of Dopamine Receptor Agonist Therapy for Parkinson's Disease

By Contin M.   Riva R.   Albani F.   Baruzzi A.  

CNS Drugs, Vol. 14, Iss. 6, 2000-12 ,pp. : 439-455

Adis International

Access to resources Recommend Favorite

Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 14, 2012-12 ,pp. : 1556-1564

Bentham Science Publishers

Access to resources Recommend Favorite

Restoration of the Striatal Dopamine Synthesis for Parkinson's Disease:Viral Vector-Mediated Enzyme Replacement Strategy

By  

Current Gene Therapy, Vol. 7, Iss. 2, 2007-04 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease

By Guillin O.   Griffon N.   Bezard E.   Leriche L.   Diaz J.   Gross C.   Sokoloff P.  

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite